Targeting epigenetic regulators using bacterial macromolecule delivery
Description: PUBLIC HEALTH RELEVANCE: The experimental plan describes a therapeutic strategy to target epigenetic tumor regulators by using bacteria to controllably deliver genes and proteins into cancer cells. In this project, bacteria will be engineered to deliver shRNA, targeting NIPP1 and EZH2, and NIPP1-based peptides that dissociate NIPP1:PP1 complexes. This research will establish a new therapeutic platform that will enable targeting of cancer genes for which no therapy currently exists.
Funder: National Cancer Institute
Funding type: research
Funder scheme: R01
Start date: 2014-09-01
End date: 2020-08-31
Investigator: NEIL S. FORBES
Institution: UNIVERSITY OF MASSACHUSETTS AMHERST
Topic: Bacterial Cancer Therapy
Subfield: Biotechnology
Domain: Life Sciences
Funded outputs count: 25
Funder award ID: R01CA188382
OpenAlex ID: G2881906363
